US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

688.64

-0.2774-0.04%

Number of Gainers:91

Number of Losers:45

Number of Flat:18

PE:- -

High:692.54

Open:689.82

Low:685.07

Close:688.92

Volume:26.17M

Turnover:1.03B

Market Cap:476.48B

Float Cap:362.58B

Loading ...

Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

THOMSON REUTERS

Cytek Biosciences: Sysmex & Cytek to Offer Integrated End-to-End Flow Cytometry Solutions

THOMSON REUTERS

Press Release: BEEP Closes Series B to Accelerate Commercial Deployment of Autonomous Mobility Networks

Cardiol Therapeutics to Showcase Cardiac Drug Pipeline at H.C. Wainwright Conference

ProQR Therapeutics doses first participant in AX-0811 clinical trial

IN8bio Appoints Oxana Polyakova, Ph.d., as Senior Vice President of Research & Development

THOMSON REUTERS

Press Release: IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Piper Sandler Initiates Oklo at Overweight

MT Newswires Live

Robinhood Stock Gains as Mizuho Says HOOD Could See Another ‘SpaceX-Like Trading Surge’

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: FIGS (FIGS), Casey’s General (CASY) and Royal Caribbean (RCL)

LifeStance Health Falls as PE Backers to Carve Stakes

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Core & Main's Q2 Sales Slightly Beat, Adjusted EPS Tops Estimates

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates

MT Newswires Live

Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 Million

Core & Main Inc Fy2026 Shr View $2.89, REV View $7.68 Bln

THOMSON REUTERS

Core & Main Q2 Adjusted EPS USD 0.94 VS. Ibes Estimate USD 0.92

THOMSON REUTERS

Core & Main Q2 Net Income USD 150 Million

THOMSON REUTERS

Core & Main - Reaffirms Full-Year Fiscal 2026 Outlook Issued in March 2026

THOMSON REUTERS

Core & Main FY26 Q2 Net Income Climbs 6.4% to $150 Million; Net Sales Rise 2.5% to $2.15 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK4539/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":688.63763,"timestamp":1789134573020,"preClose":688.91504,"halted":0,"volume":26165426,"delay":0,"changeRate":-0.000403,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.277405,"latestTime":"09-11 09:49:36 EDT","open":689.8237,"high":692.5432,"low":685.0665,"amount":1032250178.145318,"amplitude":0.010853,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322493,"peRate":139.789284,"turnoverRate":0.002145,"increases":90,"decrements":49,"flats":11,"marketCap":476484684073.875,"floatMarketCap":362584575606.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":692.5432,"amplitude":0.010853,"preClose":688.91504,"low":685.0665,"pbRate":"5.322493","latestPrice":688.63763,"volume":26165426,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.002145,"peRate":139.789284,"marketCap":476484684073.875,"floatMarketCap":362584575606.5,"timestamp":1789134573020,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":91,"down":45,"flat":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666533356","title":"Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533356","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533356?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA9DHBW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CTKB","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666336305","title":"Cytek Biosciences: Sysmex & Cytek to Offer Integrated End-to-End Flow Cytometry Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2666336305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666336305?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA9DHBW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTKB","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533392","title":"Press Release: BEEP Closes Series B to Accelerate Commercial Deployment of Autonomous Mobility Networks","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533392","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533392?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957000,"startTime":"0","endTime":"0","summary":"ROUND LED BY AUTONOMOUS VEHICLE TECHNOLOGY LEADER MOBILEYELAKE NONA, Fla., Sept. 9, 2026 /PRNewswire/ -- Beep, Inc., a leading U.S. provider of autonomous mobility solutions, today announced the close","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4157","AAQC","LU2065171402.SGD","LU2065169927.USD","BK4588","BK4555","BK4120","TM","BK4585","03160","BK4099","BK4124","BK4539","BK4604","LU2065170008.USD","BEEP","MBLY","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051538","title":"Cardiol Therapeutics to Showcase Cardiac Drug Pipeline at H.C. Wainwright Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:18","pubTimestamp":1788956307,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Cardiol Therapeutics ( ($TSE:CRDL) ). Cardiol Therapeutics said it will take part in a fireside chat at the H.C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-to-showcase-cardiac-drug-pipeline-at-h-c-wainwright-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-to-showcase-cardiac-drug-pipeline-at-h-c-wainwright-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538091","title":"ProQR Therapeutics doses first participant in AX-0811 clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538091?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956125,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics (PRQR) announced that the first participant has been dosed in the Phase 1 clinical trial of AX-0811 in healthy volunteers. Publi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-doses-first-participant-in-ax-0811-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-doses-first-participant-in-ax-0811-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LU2360107671.USD","BK4139","AX","PRQR","LU1861217088.USD","MEDX","BK4539","GDOC","BK4195","IDNA","LU1861220207.SGD","NVIB","HYLG","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666053885","title":"IN8bio Appoints Oxana Polyakova, Ph.d., as Senior Vice President of Research & Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2666053885","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666053885?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAD99RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666383835","title":"Press Release: IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2666383835","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666383835?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"Renowned <GAMMA> T cell and T cell engager (TCE) expert brings two decades of drug discovery and development experience to IN8bioAppointment strengthens IN8bio's leadership and domain expertise as the","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580049","title":"Piper Sandler Initiates Oklo at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580049","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580049?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:59","pubTimestamp":1788955190,"startTime":"0","endTime":"0","summary":"Oklo (OKLO) has an average rating of overweight and mean price target of $75.03, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","OKLL","OKLS","OKLO","OKLC","BK4539","NLR","URAN","BK4606","URA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666385665","title":"Robinhood Stock Gains as Mizuho Says HOOD Could See Another ‘SpaceX-Like Trading Surge’","url":"https://stock-news.laohu8.com/highlight/detail?id=2666385665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666385665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:59","pubTimestamp":1788955174,"startTime":"0","endTime":"0","summary":"Robinhood Markets ($HOOD) stock is up about 2% in pre-market trading on Wednesday after falling 3.91% in the previous session. The stock is getting...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/robinhood-stock-hood-is-rising-today-how-much-upside-do-analysts-see?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/robinhood-stock-hood-is-rising-today-how-much-upside-do-analysts-see?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","ROBN","HOOI","HOOW","HOOY","HOOD","HOOC","BK4539","LU1861558580.USD","BK4547","HOOX","HOOZ","LU1861559042.SGD","FINX","BPAY","CRPT","HODU","HOOG","IAI","BLCK","HOYY","HOII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580055","title":"Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: FIGS (FIGS), Casey’s General (CASY) and Royal Caribbean (RCL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580055?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:50","pubTimestamp":1788954627,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on FIGS (FIGS), Casey’s General (CASY) and Royal Caribbean (R...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-consumer-cyclical-companies-figs-figs-caseys-general-casy-and-royal-caribbean-rcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-consumer-cyclical-companies-figs-figs-caseys-general-casy-and-royal-caribbean-rcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4142","BK4202","BK4588","LU0109391861.USD","LU0672654240.SGD","LU1878469433.USD","LU1670627923.USD","BK4113","FIGS","LU0708995401.HKD","BK4517","BK4566","LU1366192091.USD","BK4198","FXG","LU1267930730.SGD","CASY","LU1670628061.USD","LU0266013472.USD","WNDR","BK4561","IE0009354923.USD","BK4585","BK4539","RCL","LU0320765059.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666416580","title":"LifeStance Health Falls as PE Backers to Carve Stakes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666416580","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666416580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:48","pubTimestamp":1788954490,"startTime":"0","endTime":"0","summary":"BUZZ-LifeStance Health falls as PE backers to carve stakesUpdates** Shares of outpatient mental healthcare provider LifeStance HealthLFST.Odown 2.7% to $12.45 premarket on Weds after launching secondary offering** Scottsdale, Arizona-based LFST says certain stockholders to part with 22.25 mln shares** In addition, LFST to repurchase 2 mln of offering shares from the underwriter Barclays** Private equity firms TPG CapitalTPG.Oand Summit Partners looking to sell ~18.41 mln shares and ~3.84 mln shares, respectively, per the prospectus** LFST has ~382.1 mln shares outstanding** Through Tues, stock up 67% over the past three months and 82% YTD** 9 of 12 analysts rate the stock \"strong buy\" or \"buy\", 3 \"hold\"; median PT $13","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4510UI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0575583348.USD","BK4539","LU2646069778.SGD","BK4135","PRVT","BK4535","LU0345770308.USD","LU0997586606.USD","LU1023061713.HKD","LU0345770993.USD","LU0964806797.USD","LU1078025761.USD","AAUM","LU0345777147.USD","LU1064927863.SGD","LU0345777659.USD","LU0171281750.USD","LU1668664300.SGD","FMED","PSP","LU0048578792.EUR","LU0550127509.SGD","IE00B3T34201.USD","LFST","BK5152","LU0161305163.EUR","LU0987226296.USD","TPG","BK4196","BARC.UK","LU0047473722.SGD","LU1791807156.HKD","LU0106831901.USD","LU1015430645.USD","LU1035777561.USD","LU1023061473.USD","LU0047473722.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666358001","title":"Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2666358001","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666358001?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:45","pubTimestamp":1788954300,"startTime":"0","endTime":"0","summary":"- Independent Safety Monitoring Committee recommends advancement to Cohort 2 following blinded review of Cohort 1 safety and tolerability data – - Pharmacokinetic observations at the lowest dose evalu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358540/0/en/serina-therapeutics-reports-cohort-1-observations-from-ser-252-registrational-study-in-advanced-parkinson-s-disease-and-advances-to-cohort-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2931357623.SGD","LU0274383776.USD","BK4007","BK4157","IE00B66KJ199.SGD","IE00B7SZL793.SGD","LENZ","SMC","BK4144","AEIS","LU1815336091.USD","LU0757428866.USD","IE0031619046.USD","BK4539","LU2089985449.USD","IE00B19Z4B17.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666989580","title":"Core & Main's Q2 Sales Slightly Beat, Adjusted EPS Tops Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666989580","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666989580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:39","pubTimestamp":1788953967,"startTime":"0","endTime":"0","summary":"Core & Main's Q2 sales slightly beat, adjusted EPS tops estimatesOverviewUS specialty distributor's fiscal Q2 net sales grew 2.5%, slightly beating analyst expectationsAdjusted EPS for fiscal Q2 beat ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N4510F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2125910179.SGD","BK4102","CNM","LU2413665964.HKD","LU1721427968.SGD","IE0009354923.USD","LU1620156213.USD","LU1620156130.USD","LU2125910336.SGD","BK4104","LU1596574779.USD","EVI","UNFI","LU1165135440.EUR","LU1923621640.USD","LU2229751404.USD","LU2413666004.HKD","LU2089279066.USD","LU1543694498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666958050","title":"Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666958050","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666958050?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:33","pubTimestamp":1788953580,"startTime":"0","endTime":"0","summary":"Schrodinger (SDGR), along with New Enterprise Associates and RA Capital Management, established a new biotechnology company named Tectora Therapeutics, according to a Wednesday statement.Concurrently,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","LENZ","EFSC","SDGR","BK4167","BK4139","BK4585","BK4211","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258054","title":"Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258054","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258054?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:32","pubTimestamp":1788953520,"startTime":"0","endTime":"0","summary":"BRIEF-Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 MillionSep 09 (Reuters) - Core & Main Q2 adjusted EBITDA USD 274 million vs. IBES estimate USD 280.7 million.Q2 adjusted EPS USD 0.94 vs. IBES estimate USD 0.92Q2 EPS USD 0.77Q2 net income USD 150 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413665964.HKD","BK4104","LU2125910179.SGD","LU1620156130.USD","BK4539","LU1543694498.USD","LU2125910336.SGD","LU2229751404.USD","LU1165135440.EUR","LU2089279066.USD","LU2413666004.HKD","LU1923621640.USD","LU1721427968.SGD","LU1596574779.USD","LU1620156213.USD","IE0009354923.USD","CNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580567","title":"Core & Main Inc Fy2026 Shr View $2.89, REV View $7.68 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580567?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910336.SGD","BK4104","LU2413665964.HKD","LU2413666004.HKD","LU1923621640.USD","CNM","IE0009354923.USD","LU2089279066.USD","LU2229751404.USD","LU2125910179.SGD","LU1596574779.USD","LU1721427968.SGD","BK4539","LU1165135440.EUR","LU1620156130.USD","LU1620156213.USD","LU1543694498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580325","title":"Core & Main Q2 Adjusted EPS USD 0.94 VS. Ibes Estimate USD 0.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580325","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580325?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2413665964.HKD","BK4539","BK4104","LU1620156130.USD","LU2125910179.SGD","LU1923621640.USD","LU2125910336.SGD","CNM","LU1543694498.USD","LU1596574779.USD","LU2413666004.HKD","LU2229751404.USD","IE0009354923.USD","LU1721427968.SGD","LU1165135440.EUR","LU1620156213.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580320","title":"Core & Main Q2 Net Income USD 150 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580320?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910336.SGD","LU1596574779.USD","IE0009354923.USD","BK4539","LU1620156213.USD","LU2089279066.USD","BK4104","LU2229751404.USD","LU1543694498.USD","LU2125910179.SGD","LU2413666004.HKD","LU1165135440.EUR","CNM","LU1923621640.USD","LU1721427968.SGD","LU1620156130.USD","LU2413665964.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309580","title":"Core & Main - Reaffirms Full-Year Fiscal 2026 Outlook Issued in March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2413666004.HKD","LU2089279066.USD","LU1596574779.USD","IE0009354923.USD","BK4104","LU1620156130.USD","LU1620156213.USD","LU2125910179.SGD","LU2229751404.USD","BK4539","LU1165135440.EUR","LU2125910336.SGD","LU1543694498.USD","LU1923621640.USD","CNM","LU2413665964.HKD","LU1721427968.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580537","title":"Core & Main FY26 Q2 Net Income Climbs 6.4% to $150 Million; Net Sales Rise 2.5% to $2.15 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580537","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580537?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:30","pubTimestamp":1788953456,"startTime":"0","endTime":"0","summary":"Core & Main FY26 Q2 net income climbs 6.4% to $150 million; net sales rise 2.5% to $2.15 billionCore & Main posted fiscal 2026 Q2 net sales up 2.5% to $2.15 billion versus the prior-year quarter.GAAP ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6TL72h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","LU1620156130.USD","LU1620156213.USD","LU1721427968.SGD","LU1923621640.USD","LU2413665964.HKD","BK4539","CNM","LU2413666004.HKD","BK4104","LU2125910179.SGD","IE0009354923.USD","LU2125910336.SGD","LU1543694498.USD","LU1596574779.USD","LU2229751404.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":10,"totalSize":896,"code":"91000000","status":"200"}]}}